return to news
  1. MobiKwik vs Vishal Mega Mart vs Sai Life Sciences: Key points

Market News

MobiKwik vs Vishal Mega Mart vs Sai Life Sciences: Key points

Upstox

2 min read | Updated on December 13, 2024, 09:23 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

MobiKwik's ₹572 crore IPO is exclusively a fresh issue of equity shares with no offer-for-sale component. Its price band has been fixed at ₹265-₹279 per share.

All three IPOs went live on December 11.

All three IPOs went live on December 11.

The initial public offerings of MobiKwik, Vishal Mega Mart, and Sai Life Sciences will conclude on Friday, December 13. Their allotment statuses are likely to be finalised on December 16, and the shares will be listed on the NSE and the BSE on December 18.

All three IPOs went live on December 11.

MobiKwik IPO

One MobiKwik Systems' ₹572 crore IPO is exclusively a fresh issue of equity shares with no offer-for-sale component. Its price band has been fixed at ₹265-₹279 per share.

The initial share sale received a robust response from investors, with the issue being subscribed 20.37 times until day 2. Retail investors attracted 64.52 times subscription, while non-institutional investors picked up 30 times subscription. The part set aside for qualified institutional buyers (QIBs) mopped up 84% subscription.

Before the IPO, the company raised ₹257 crore from anchor investors.

Vishal Mega Mart IPO

The ₹8,000 crore IPO of Vishal Mega Mart has been subscribed 1.53 times, with NIIs bidding 3.80 times, retail investors 1.16 times and QIBs 48%.

The issue is completely an offer-for-sale of equity shares by promoter Samayat Services LLP, which is led by Kedaara Capital. There is no fresh issue component. The price band has been set at ₹74-₹78 per share.

Prior to the IPO, Vishal Mega Mart had mobilised ₹2,400 crore from anchor investors.

ICICI Securities, Intensive Fiscal Services, Jefferies India, Kotak Mahindra Capital Company, Morgan Stanley India Company and JP Morgan India are the book-running lead managers for the issue.

Sai Life Sciences IPO

Sai Life Sciences IPO, with a price band of ₹522-₹549 apiece, was subscribed 1.25 times until the second day of bidding. The QIBs received 3.32 times the subscription, while the NIIs received 59%. The portion for retail investors received 42% subscription.

The ₹3,042.62 crore initial share sale consists of a fresh issue valued at ₹950 crore and an OFS of 3.81 crore shares.

Of the IPO proceeds, around ₹600 crore will be used for debt repayment and some for general corporate purposes.

To learn more about IPO listings, schedules, and upcoming IPOs, visit our page.

About The Author

Upstox
Upstox News Desk is a team of journalists who passionately cover stock markets, economy, commodities, latest business trends, and personal finance.

Next Story